DFFA / ICAD / DFF45 Antibody (aa2-21)
Rabbit Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB, IHC-P |
---|---|
Primary Accession | O00273 |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Calculated MW | 37kDa |
Dilution | IHC-P (10 µg/ml), WB (1:1000-1:2000), |
Gene ID | 1676 |
---|---|
Other Names | DNA fragmentation factor subunit alpha, DNA fragmentation factor 45 kDa subunit, DFF-45, Inhibitor of CAD, ICAD, DFFA, DFF1, DFF45 |
Target/Specificity | peptide corresponding to amino acids 2 to 21 of human DFF45 |
Reconstitution & Storage | Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles. Store undiluted. |
Precautions | DFFA / ICAD / DFF45 Antibody (aa2-21) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | DFFA |
---|---|
Synonyms | DFF1, DFF45 |
Function | Inhibitor of the caspase-activated DNase (DFF40). |
Cellular Location | Cytoplasm. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Inhibitor of the caspase-activated DNase (DFF40).
References
Liu X.,et al.Cell 89:175-184(1997).
Gu J.J.,et al.J. Biol. Chem. 274:20759-20762(1999).
Oh J.J.,et al.Nucleic Acids Res. 27:4008-4017(1999).
Kalnine N.,et al.Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
Ota T.,et al.Nat. Genet. 36:40-45(2004).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.